|
시장보고서
상품코드
2058296
임상 진단 시장 : 검사별, 제품별, 최종사용자별, 지역별Clinical Diagnostic Market, By Test, By Product, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
임상 진단 시장은 2026년에 868억 달러로 추정되며, 2033년까지 1,238억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 868억 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.50% | 2033년 시장 규모 예측: | 1,238억 달러 |
임상 진단이란 환자가 보이는 징후와 증상, 병력 및 신체 검사를 바탕으로 질환, 병세 또는 외상을 특정하는 과정입니다. 임상 진단은 질병의 예방, 조기 발견 및 관리에도 유용하다는 것이 밝혀졌습니다. 이러한 검사는 만성 질환, 감염증, 자가면역 질환 등 다양한 질환의 진단 및 모니터링에 도움이 되며, 약물 치료의 분석에도 활용되고 있습니다.
시장 역학
만성 질환 및 감염병의 부담 증가, 임상 진단 활용 확대, 고령 인구 증가, 연구 개발 활성화, 그리고 전 세계적인 COVID-19 유행이 세계 임상 진단 시장의 성장을 견인할 것으로 예상됩니다.
예를 들어, 2020년 9월, 미국 국립보건원(NIH)은 'Rapid Acceleration of Diagnostics(RADx)' 이니셔티브의 일환으로, 새로운 일련의 COVID-19 검사 기술 생산 지원을 확대하기 위해 9개 기업에 1억 2,930만 달러를 지원할 계획을 세웠습니다. 또한, 2020년 3월에는 유럽연합 집행위원회의 연구·혁신 프레임워크 프로그램인 '호라이즌 2020'의 지원을 받는 혁신 의약품 이니셔티브(IMI)가, 진단 포트폴리오 혁신에 힘쓰고 있는 5개 기관에 7,200만 유로의 자금을 지원한다고 발표했습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 보고서에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 임상 진단 시장의 주요 기업 개요을 소개하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 임상 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 임상 진단 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 임상 진단 시장 : 유형별, 2021-2033년
제5장 세계의 임상 진단 시장 : 제품별, 2021-2033년
제6장 세계의 임상 진단 시장 : 최종사용자별, 2021-2033년
제7장 세계의 임상 진단 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.19Clinical Diagnostic Market is estimated to be valued at USD 86.8 Bn in 2026 and is expected to reach USD 123.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 86.8 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.50% | 2033 Value Projection: | USD 123.8 Bn |
Clinical diagnostic is the process of identifying a disease, condition, or injury based on the signs & symptoms a patient is having and patient's health history and physical exam. Clinical diagnostics have been also found to be valuable for the prevention, detection, and management of the disease. These tests help detect and monitor many medical conditions, such as chronic diseases, infectious diseases, and autoimmune diseases that are being used to analyze drug therapies.
Market Dynamics
Growing burden of chronic and infectious diseases, increase in use of clinical diagnostic, growing geriatric population, increase in research and development, and outbreak of COVID-19 worldwide are expected to drive growth of the global clinical diagnostic market.
For instance, in September 2020, the National Institutes of Health (NIH) planned to give a funding of US$ 129.3 million to 9 companies to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of Rapid Acceleration of Diagnostics (RADx) initiative. Moreover, in March 2020, Innovative Medicines Initiative (IMI), supported by the European Commission's Horizon 2020 Framework Programme for Research and Innovation, announced EUR 72 million funding to five organizations working to innovate diagnostic portfolios.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global clinical diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Qiagen N.V, Hologic Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter, Inc.), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global clinical diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical diagnostic market.
Market Segmentation
- By Test (Revenue, USD Bn, 2021-2033)
- Lipid Panel
- Liver Panel
- Renal Panel
- Complete Blood Count
- Electrolyte Testing
- Infectious Disease Testing
- Other Tests
- By Product (Revenue, USD Bn, 2021-2033)
- Instruments
- Reagents
- Other Products
- By End User (Revenue, USD Bn, 2021-2033)
- Hospital Laboratory
- Diagnostic Laboratory
- Point-of-Care Testing
- Other End Users
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Thermo Fisher Scientific
- Hoffmann-La Roche AG
- Qiagen N.V
- Hologic Inc.
- Siemens Healthineers AG
- BioMerieux SA
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Becton, Dickinson and Company
- Danaher Corporation (Beckman Coulter, Inc.)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing burden of infectious and chronic diseases worldwide
- High cost of high-end molecular diagnostics
- The outbreak of COVID-19 (global pandemic)
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Clinical Diagnostic Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Lipid Panel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Liver Panel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Renal Panel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Complete Blood Count
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Electrolyte Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Infectious Disease Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Clinical Diagnostic Market, By Product, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Clinical Diagnostic Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diagnostic Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Point-of-Care Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other End Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Clinical Diagnostic Market, By Geography, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen N.V
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Beckman Coulter, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
